Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

about

Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes.

P2860

Q55408800-6CC799F7-2472-4745-9C0E-C82C77A17ABB

P2860

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

Item

http://www.wikidata.org/entity/Q45997189

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

@en

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

@nl

type

Item

label

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

@en

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

@nl

prefLabel

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

@en

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

@nl

P1476

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

@en

P2093

Audrey V Parent

http://www.w3.org/2001/XMLSchema#string

Daniel A Bernards

http://www.w3.org/2001/XMLSchema#string

Gaetano Faleo

http://www.w3.org/2001/XMLSchema#string

Holger A Russ

http://www.w3.org/2001/XMLSchema#string

Jessica L Allen

http://www.w3.org/2001/XMLSchema#string

Karina Villanueva

http://www.w3.org/2001/XMLSchema#string

Matthias Hebrok

http://www.w3.org/2001/XMLSchema#string

Qizhi Tang

http://www.w3.org/2001/XMLSchema#string

Susanna K Elledge

http://www.w3.org/2001/XMLSchema#string

Tejal A Desai

http://www.w3.org/2001/XMLSchema#string

P2860

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

Generation of functional human pancreatic β cells in vitro

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells

Efficient differentiation of human embryonic stem cells to definitive endoderm

Improvement in outcomes of clinical islet transplantation: 1999-2010.

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

INS(GFP/w) human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells

Five-year follow-up after clinical islet transplantation.

P304

7747-7757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSNANO.7B01239

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ryan Chang

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28763191

http://www.w3.org/2001/XMLSchema#string

P932

5667644

http://www.w3.org/2001/XMLSchema#string

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

about

P2860

P2860

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932